Daalụ maka ileta Nature.com.Ụdị ihe nchọgharị ị na-eji nwere nkwado CSS nwere oke.Maka ahụmịhe kachasị mma, anyị na-akwado ka ị jiri ihe nchọgharị emelitere (ma ọ bụ gbanyụọ ọnọdụ ndakọrịta na Internet Explorer).Ka ọ dị ugbu a, iji hụ na nkwado na-aga n'ihu, anyị ga-enye saịtị ahụ na-enweghị ụdị na Javascript.
A na-ejikarị peptide na protein agwọ ọrịa dị iche iche, mana a na-agbakarị ha ọgwụ, mmetụta ha anaghị adịte aka.Enwere ike iwepụ adịghị ike ndị a nke ihe owuwu ala site n'enyemaka nke injinịa molecular, mana nke a bụ ọrụ siri ike.Usoro injinia molekụla, nke etinyere na mbụ na insulin ma tinyezie ya nke ọma na ọtụtụ biopharmaceuticals, chọrọ iwepụ peptides na protein sitere na fatty acids.Njirimara akọwapụtara na ọnọdụ nke fatty acids nwere ike inye usoro elongation dị iche iche.Tụkwasị na nke a, nkà na ụzụ a nwere ike inye ogologo oge ọkara ndụ mgbe nchịkwa ọnụ nke ọgwụ peptide gasịrị, nwere ike gbanwee nkesa nke peptides, ma nwee ike ịmebe anụ ahụ.Site na nchekwa dị n'ime nke acid fatty acid na njirimara kemịkalụ akọwapụtara nke ọma, teknụzụ a na-enye ụzọ dị iche iche maka nchọpụta peptide na protein ọgwụ.
Ọnụ ahịa niile dị ụgbụ.A ga-agbakwunye VAT ma emechaa na ndenye ọpụpụ.A ga-eme ngụkọ ụtụ isi na ndenye ọpụpụ.
Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Trends na nchọpụta ọgwụ peptide. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Trends na nchọpụta ọgwụ peptide.Muttenthaler, M., King, GF, Adams, DJ na Alevud, PF Trends na nchọpụta ọgwụ peptide. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF 多肽药物发现的趋势。 Muttenthaler, M., King, GF, Adams, DJ & Alewood, PFMuttenthaler, M., King, GF, Adams, DJ na Alevud, PF Trends na nchọpụta ọgwụ peptide.Mba mmeghe nke pastọ ọgwụ.20, 309–325 (2021).Nlebanya a lekwasịrị anya n'ihe dị ugbu a na n'ọdịnihu nke nchọpụta ọgwụ peptide.
Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Nchọpụta ọgwụ mgbochi oke ibu: ọganihu na ihe ịma aka. Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Nchọpụta ọgwụ mgbochi oke ibu: ọganihu na ihe ịma aka.Müller, TD, Blucher, M., Chop, MH na DiMarchi, RD Nchọpụta ọgwụ mgbochi oke ibu: ọganihu na ihe ịma aka. Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD 抗肥胖药物发现：进展和挑战。 Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RDMüller, TD, Blucher, M., Chop, MH na DiMarchi, RD Nchọpụta ọgwụ mgbochi oke ibu: ọganihu na ihe ịma aka.Mba mmeghe nke pastọ ọgwụ.21, 201–223 (2022).Nyocha a na-enye nghọta na nsogbu nke oke ibu, karịsịa echiche ọhụrụ dabere na peptides.
Strohl, WR Fusion protein ịgbatị ọkara ndụ nke ihe ndị dị ndụ dị ka atụmatụ kachasị mma maka ihe ndị dị ndụ.Biopharmaceutics 29, 215-239 (2015).
Evans, M. et al.Nrapara na nnọgidesi ike nke ọgwụ antidiabetic na mkpakọrịta na nsonaazụ ụlọ ọgwụ na nke akụ na ụba na ndị ọrịa nwere ụdị ọrịa shuga 2: nyocha usoro nke akwụkwọ.oke ibu nke ọrịa shuga.metabolism.24, 377–390 (2022).
Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Nleba anya ndị ọrịa na ọgwụ kwa izu otu ugboro maka ọrịa shuga. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Nleba anya ndị ọrịa na ọgwụ kwa izu otu ugboro maka ọrịa shuga.Polonsky WH, Fisher L., Hessler D., Brune D., na Best JH Echiche onye ọrịa gbasara ọgwụ shuga kwa izu otu ugboro. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH 患者对每周一次的糖尿病药物的看法。 Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JHPolonsky WH, Fisher L., Hessler D., Brune D., na Best JH Patient echiche banyere ọgwụ shuga shuga otu ugboro kwa izu.oke ibu nke ọrịa shuga.metabolism.13, 144–149 (2011).
Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis nke palmitoyl ewepụtara insulin na ihe omume ha. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis nke palmitoyl ewepụtara insulin na ihe omume ha.Hashimoto M., Takada K., Kiso Y. na Muranishi S. Nkwekọrịta nke palmitoyl nke insulin na ọrụ ndụ ha. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. 胰岛素棕榈酰衍生物的合成及其生物活性。 Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis na ọrụ ndu nke insulin palmitoyl sitere na ya.Hashimoto M., Takada K., Kiso Y. na Muranishi S. Nkwekọrịta na ọrụ ndu nke insulin palmitoyl.mmiri mmiri ọgwụ 6, 171-176 (1989).
Kurthals, P. et al.Albumin na-ejikọta na insulin fatty acid-acylated: njirimara nke mmekọrịta ligand-protein na njikọ dị n'etiti njikọ njikọ na oge insulin na-arụ ọrụ na vivo.biochem.J. 312, 725–731 (1995).Ọrụ a bụ nke mbụ gosipụtara mmụba nke ọkara ndụ n'ihi njikọ nke albumin na peptides sitere na fatty acids.
Mejuch, T. & Waldmann, H. Njikọ nke protein lipidated. Mejuch, T. & Waldmann, H. Njikọ nke protein lipidated.Meyukh, T. na Waldmann, H. Njikọ nke protein lipidated. Mejuch, T. & Waldmann, H. 脂化蛋白质的合成。 Mejuch, T.& Waldmann, H.Meyukh, T. na Waldmann, H. Njikọ nke protein lipidated.Bioconjugate.Chemical.27, 1771–1783 (2016).
Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein lipidation na cell signaling na ọrịa: ọrụ, ụkpụrụ, na ohere ọgwụgwọ. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein lipidation na cell signaling na ọrịa: ọrụ, ụkpụrụ, na ohere ọgwụgwọ.Chen B., Sun Y., Niu J., Jarugumilli GK na Wu X. Protein lipidation na cell signaling na ọrịa: ọrụ, ụkpụrụ, na ike ọgwụgwọ. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein 脂化 na akara cell na ọrịa: ọrụ, ụkpụrụ na ohere ọgwụgwọ.Chen B., Sun Y., Niu J., Jarugumilli GK na Wu X. Protein lipidation na cell signaling na ọrịa: ọrụ, ụkpụrụ, na ike ọgwụgwọ.cytochemistry.bayoloji 25, 817–831 (2018).
Richter, WF, Bhansali, SG & Morris, ME Mechanistic na-ekpebi nnabata biotherapeutics na-eso nchịkwa SC. Richter, WF, Bhansali, SG & Morris, ME Mechanistic na-ekpebi nnabata biotherapeutics na-eso nchịkwa SC.Richter, VF, Bhansali, SG na Morris, ME Mechanisms na-ekpebi nnabata nke ọgwụ biotherapeutic mgbe nchịkwa subcutaneous gasịrị. Richter, WF, Bhansali, SG & Morris, ME SC 给药后生物治疗药物吸收的机制决定因素。 Richter, WF, Bhansali, SG & Morris, ME SC Richter, WF, Bhansali, SG & Morris, ME SC Механистические детерминанты Richter, WF, Bhansali, SG & Morris, ME SC Mechanistic na-ekpebi nnabata nke ọgwụ biotherapeutic mgbe nchịkwachara.AAPS J. 14, 559–570 (2012).
Gradel, AKJ et al.Ihe na-emetụta nnabata insulin subcutaneous: mmetụta maka mgbanwe.J. Ọrịa shuga Res.2018, 1205121 (2018).
Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion na polymerization na-ekpebi nnabata insulin site na anụ ahụ subcutaneous na ndị ọrịa nwere ọrịa shuga. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion na polymerization na-ekpebi nnabata insulin site na anụ ahụ subcutaneous na ndị ọrịa nwere ọrịa shuga. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Диффузия и пределяют овс диабетом. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion na polymerization na-ekpebi nnabata insulin site na anụ ahụ subcutaneous na ndị ọrịa nwere ọrịa shuga. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Диффузия и агрегация nke ọma. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Diffusion na mkpokọta na-ekpebi nnabata insulin subcutaneous na ndị ọrịa nwere ọrịa shuga.nyocha.J. Klin.ụlọ nyocha.itinye ego.45, 685–690 (1985).
Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Modeling absorption kinetics nke subcutaneous gbanyere soluble insulin. Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Modeling absorption kinetics nke subcutaneous gbanyere soluble insulin.Mosekilde E, Jensen KS, Binder S, Pramming S, na Thorsteinsson B. Na-egosiputa usoro nnabata nke insulin soluble subcutaneous. Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. 模拟皮下注射可溶性胰岛素的吸收动力学。 Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B.Mosekilde E, Jensen KS, Binder S, Pramming S, na Thorsteinsson B. Na-egosiputa usoro nnabata nke insulin soluble na-esi n'okpuru akpụkpọ ahụ.J. Pharmacokinetics.biopharmacy.17, 67–87 (1989).
Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III nha molekul na-agbanwe ọgwụ ọgwụ, biodistribution, na ntinye akụrụ nke nnyefe ọgwụ biopolymer elastin dị ka polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III nha molekul na-agbanwe ọgwụ ọgwụ, biodistribution, na ntinye akụrụ nke nnyefe ọgwụ biopolymer elastin dị ka polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III ноподобного полипептида для доставки лекарственного средства. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Molecular size modulates pharmacokinetics, biodistribution, na renal ntinye nke biopolymeric elastin dị ka polypeptide maka nnyefe ọgwụ. Ee, M. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Molecule 大小名行电影送送 biological polymer elastic protein sample.Kuna, M., Mahdi, F., Chad, AR na Bidwell, GL III.Pharmacokinetics, biodistribution na renal ntinye nke biopolymeric elastin dị ka polypeptides na-agbanwe nha nke molekul.Akụkọ sayensị 8, 7923 (2018).
Harris, JM, Martin, NE & Modi, M. Pegylation: usoro ọhụrụ maka imeghari ọgwụ ọgwụ. Harris, JM, Martin, NE & Modi, M. Pegylation: usoro ọhụrụ maka imeghari ọgwụ ọgwụ. Harris, JM, Martin, NE & Modi, M. Пегилирование: akwụkwọ akụkọ ihe nkiri. Harris, JM, Martin, NE & Modi, M. Pegylation: usoro ọhụrụ maka imeghari ọgwụ ọgwụ. Harris, JM, Martin, NE & Modi, M. 聚乙二醇化：一种改变药代动力学的新方法。 Harris, JM, Martin, NE & Modi, M. 聚乙二感化: usoro ọhụrụ nke ịgbanwe ọgwụ. Harris, JM, Martin, NE & Modi, M. Пегилирование. Harris, JM, Martin, NE & Modi, M. Pegylation: a ọhụrụ ụzọ na-agbanwe pharmacokinetics.ụlọ ọgwụ.Pharmacokinetics.40, 539–551 (2001).
Elmerer, M. et al.Ntụle albumin interstitial n'ime akwara skeletal mmadụ na anụ ahụ adipose site na microperfusion mepere emepe.Ee.J. Physiology.endocrine.metabolism.278, E352-E356 (2000).
Nelson, J. et al.Ogologo ndụ ọkara ndụ albumin n'ime mmadụ chọrọ C-terminus na-emebibeghị.nkwurịta okwu.bayoloji.3, 181 (2020).
Chowdhury, K. et al.Ihe nnabata Fc (FcRn) maka IgG jikọtara ya na nnukwu ihe mgbagwoju anya histocompatibility na-ejikọ albumin ma na-agbatị ndụ ya.J. Exp.ọgwụ.197, 315–322 (2003).
Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis nke IgG dị ka onye na-anabata ya, FcRn: nyocha na ọkwa otu-molecule. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis nke IgG dị ka onye na-anabata ya, FcRn: nyocha na ọkwa otu-molecule. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Эkzotsytoz IgG, oposredovanny ndị ọrụ FcRn. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES FcRn receptor-mediated IgG exocytosis: nyocha otu-molecule. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES 受体介导的IgG 胞吐作用，FcRn：单分子水平的分析。 Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, Эkzotsytoz IgG, oposredovannыy рецеptorom ES, FcRn: анализ на уровне одный. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES receptor-mediated IgG exocytosis, FcRn: otu nyocha ọkwa ọkwa molecule.usoro.National Academy of Science.sayensị.US 101, 11076 (2004).
Ya, XM & Carter, DC Atomic Ọdịdị na kemịkalụ nke serum albumin mmadụ. Ya, XM & Carter, DC Atomic Ọdịdị na kemịkalụ nke serum albumin mmadụ.On, XM na Carter, DC Atomic Ọdịdị na kemịkalụ nke serum albumin mmadụ. He, XM & Carter, DC 人血清白蛋白的原子结构和化学。 Ọ, XM & Carter, DC.On, XM na Carter, DC Atomic Ọdịdị na kemịkalụ nke serum albumin mmadụ.Ọdịdị 358, 209-215 (1992).
Curry, S., Mandelkow, H., Brick, P. & Franks, N. Crystal Ọdịdị nke mmadụ serum albumin complexed na fatty acid na-ekpughe ihe asymmetric nkesa nke njikọ. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Crystal Ọdịdị nke mmadụ serum albumin complexed na fatty acid na-ekpughe ihe asymmetric nkesa nke njikọ.Curry S., Mandelkow H., Brick P. na Franks N. Ọdịdị kristal nke serum albumin mmadụ na mgbagwoju anya nwere fatty acid na-egosi nkesa asymmetric nke saịtị njikọ. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Ọdịdị kristal nke serum ọcha protein complex na fatty acids na-ekpughe ihe nkesa asymmetric nke saịtị njikọ.Curry S., Mandelkow H., Brick P. na Franks N. Ọdịdị kristal nke serum albumin mmadụ na mgbagwoju anya nwere abụba abụba na-egosi nkesa asymmetric nke saịtị njikọ.Mba.nhazi.bayoloji 5, 827–835 (1998).Akwukwo a gosiputara ihe ndabere nke ejiko fatty acids na serum albumin.
Irby, D., Du, C. & Li, F. Lipid – ọgwụ conjugate maka ịkwalite nnyefe ọgwụ. Irby, D., Du, C. & Li, F. Lipid – ọgwụ conjugate maka ịkwalite nnyefe ọgwụ.Irby, D., Du, K. na Li, F. Lipid-ọgwụ conjugates maka nkwalite nnyefe ọgwụ. Irby, D., Du, C. & Li, F. Lipid-ọgwụ conjugate maka ịkwalite nnyefe ọgwụ. Irby, D., Du, C. & Li, F. Lipid-ọgwụ conjugate maka ịkwalite nnyefe ọgwụ.Irby, D., Du, K. na Li, F. Lipid-ọgwụ conjugate maka nkwalite nnyefe ọgwụ.Biochemistry 14, 1325–1338 (2017).
Torchilin VP Ọganihu na-adịbeghị anya na ngalaba nke liposomes dị ka ndị na-ebu ọgwụ.Mba mmeghe nke pastọ ọgwụ.4, 145–160 (2005).
Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Ohere na ihe ịma aka nke fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Ohere na ihe ịma aka nke fatty acid conjugated therapeutics.Bhat, M., Jatyan, R., Mittal, A., Mahato, RI na Chitkara, D. Ohere na ihe ịma aka nke fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战。 Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Fatty acid 共续电影的机遇和 ịma aka.Bhat M., Jatyan R., Mittal A., Mahato RI na Chitkara D. Ohere na ihe ịma aka nke ọgwụgwọ njikọta abụba acid.Chemical.physics Lipids 236, 105053 (2021).
Smith, R. & Tanford, C. Hydrophobicity nke ogologo yinye n-alkyl carboxylic acids, dị ka atụpụtara site na nkesa ha n'etiti heptane na ngwọta mmiri. Smith, R. & Tanford, C. Hydrophobicity nke ogologo yinye n-alkyl carboxylic acids, dị ka atụpụtara site na nkesa ha n'etiti heptane na ngwọta mmiri.Smith, R. na Tanford, K. Hydrophobicity nke ogologo yinye n-alkylcarboxylic acid tụrụ site na nkesa ha n'etiti heptane na ngwọta mmiri. Smith, R. & Tanford, C. 长链正烷基羧酸的疏水性，通过它们在庚烷和水溶液之间的分布来测量。 Smith, R. & Tanford, C. The hydrophobicity nke 长链正alkylcarboxylate, tụrụ site na nkesa ha n'etiti hydrogen peroxide na aqueous ngwọta.Smith, R. na Tanford, K. Hydrophobicity nke ogologo yinye n-alkylcarboxylic acid tụrụ site na nkesa ha n'etiti heptane na ngwọta mmiri.usoro.National Academy of Sciences.sayensị US 70, 289 (1973).
Liu, J. et al.Nchọpụta otu ugboro kwa izu nke semaglutide analog nke glucagon-dị ka peptide-1 (GLP-1).J. Ọgwụ.Chemical.58, 7370–7380 (2015).Ọrụ a na-egosipụta na nke mbụ ohere nke iji otu ugboro n'izu ụzọ mwepu acid fatty acid.
Østergaard, S. et al.Mmetụta nke mmadụ PYY3-36 dibasic fatty acid acylation na mini-pig Y2 ọrụ nnabata na ọkara ndụ.sayensị.Akụkọ 11, 21179 (2021).Edemede a na-egosi mkpa ọ dị n'ọnọdụ acid fatty, njikọ njikọ na nkwụsi ike nke azụ na mmepe nke ogologo ọkara ndụ PYY analogs.
Ensenat-Vaser, R. et al.A na-ahụ ntinye peptides myristoylated n'ofe akpụkpọ ahụ cell ozugbo site na iji confocal fluorescence microscopy.Ndụ IUBMB 54, 33–36 (2002).
Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl na-ebufe peptides n'ime sel dị ndụ. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl na-ebufe peptides n'ime sel dị ndụ.Nelson AR, Borland L, Allbritton NL.na Sims SE Peptide njem n'ime sel dị ndụ dabere na myristoyl. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Nelson, AR, Borland, L., Allbritton, NL & Sims, CE.Nelson, AR, Borland, L., Albritton, NL.na Sims, KE Ụgbọ njem nke peptides dabeere na myristoyl n'ime sel dị ndụ.Biochemistry 46, 14771–14781 (2007).
Kabanov, AV, Levashov, AV & Alakhov, VY Lipid mgbanwe nke protein na akpụkpọ ahụ ha na-ebufe. Kabanov, AV, Levashov, AV & Alakhov, VY Lipid mgbanwe nke protein na akpụkpọ ahụ ha na-ebufe.Kabanov AV, Levashov AV, Alakhov V.Yu.Mgbanwe nke egbugbere ọnụ nke protein na mbufe akpụkpọ ahụ ha. Kabanov, AV, Levashov, AV & Alakhov, VY 蛋白质的脂质修饰及其膜转运. Kabanov, AV, Levashov, AV & Alakhov, VYKabanov AV, Levashov AV, Alakhov, Lipid mgbanwe nke protein VY na akpụkpọ ha ebuga.injinia protein.Dec. Searl.3, 39–42 (1989).
Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Fatty acylation na-eme ka cellular internalization na nkesa cytosolic nke cystine-knot peptide. Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Fatty acylation na-eme ka cellular internalization na nkesa cytosolic nke cystine-knot peptide.Gao, X., Mazier, AD, Byrd, R., Klumperman, J. na Hannoosh, RN Fatty acid acylation na-eme ka cellular internalization na cytosolic nkesa nke peptide nwere loop cystine. Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN.Gao, X., Mazier, AD, Byrd, R., Klumperman, J. na Hannoosh, RN Fatty acylation na-akwalite cellular internalization na cytoplasmic nkesa nke cystine peptides.iScience 24, 103220 (2021).
Baker, EM et al.Mgbanwe nke ọkara ndụ-agbatị nke peptide YY3-36 maka ntinye aka na-anabata ndị nnabata ozugbo.Moore.ọgwụ.16, 3665–3677 (2019).
Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG ọnọdụ na ogologo nke ọdụdụ asịd na-emetụta ike anabata usoro nhọrọ nke mmadụ pancreatic polypeptide analogues. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG ọnọdụ na ogologo nke ọdụdụ asịd na-emetụta ike anabata usoro nhọrọ nke mmadụ pancreatic polypeptide analogues.Mere, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. na Beck-Sickinger, AG Ọnọdụ na ogologo nke fatty acids na-emetụta usoro nhọrọ nke ndị na-anabata analọg polypeptide pancreatic mmadụ. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil er, J. & Beck-Sickinger, AG 脂肪酸ị. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil'er, J. & Beck-Sickinger, AGMere, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. na Beck-Sickinger, AG Ọnọdụ na ogologo nke fatty acids na-emetụta usoro nhọrọ nke ndị na-anabata analọg polypeptide pancreatic mmadụ.HimMedChem 9, 2463–2474 (2014).
Alexopoulou, F. et al.Metabolite lipid PrRP31 bụ GPR10 na-eme ogologo oge na onye na-anabata NPFF2 nwere mmetụta ọnwụ dị arọ.sayensị.Akụkọ 12, 1696 (2022).Ọmụmụ usoro a na-akọwapụta ọdịiche dị n'etiti ụdọ akụkụ mono- na diacid.
Poulsen, K. et al.Mmepe ezi uche nke ndị agonists kwụsiri ike nke Y2 receptor peptide PYY3-36.ọgwụ.tankị nchekwa.38, 1369–1385 (2021).
Conde-Frieboes, K. et al.Nchọpụta na njirimara nke in vitro na in vivo analogues nke melanocortin 4 receptor (MC4-R) alpha-melanocytes na-akpali akpali (alpha-MSH).J. Ọgwụ.Chemical.55, 1969–1977 (2012).
Ramirez-Andersen, HS et al.Analọgụ homonụ na-eto mmadụ na-eme ogologo oge jikọtara ya na albumin na-abụghị covalent.Bioconjugate.Chemical.29, 3129–3143 (2018).
Madsen, K. et al.Mmekọrịta nhazi-mmekọrịta na elonging nke glucagon-dị ka peptide-1 na-eme ogologo oge: mkpa nke ogologo acid fatty acid, polarity, na olu.J. Ọgwụ.Chemical.50, 6126–6132 (2007).
Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Mwepụta GLP-1 okpukpu abụọ-acylated. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Mwepụta GLP-1 okpukpu abụọ-acylated. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Ugboro abụọ acylated ewepụtara nke GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Диацилированные производные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Diacylated ewepụtara nke GLP-1.Patent US WO2012/140117 (2012).
Nwa okorobịa, P.-Yu.Chere.Analogs GLP-1 nwere ike, na-eme ogologo oge emebere maka nnyefe transdermal dabere na microstructure.usoro.National Academy of Science.sayensị.US 113, 4140–4145 (2016).
Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Nyocha nchekwa, nnabata, pharmacokinetics, na pharmacodynamics nke otu na otutu doses nke analọg α-MSH na-eme ogologo oge na oke ibu na oke ibu. isiokwu. Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Nyocha nchekwa, nnabata, pharmacokinetics, na pharmacodynamics nke otu na otutu doses nke analọg α-MSH na-eme ogologo oge na oke ibu na oke ibu. isiokwu.Royalty, JE, Konradsen, G., Eskerod, O., Wolf, BS na Hansen, BS Safety, tolerability, pharmacokinetics, na pharmacodynamics ọmụmụ nke otu na otutu doses nke α-MSG analog na-eme ogologo oge na oke ibu na oke ibu.版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS 单剂量和多剂量长效α-MSH耐受性、药代动力学和药效学研究科目。版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Single dosage na multi dosage ogologo mmetụta α-MSH学和药效学研究科目。Royalty, JE, Konradsen, G., Eskerod, O., Wolf, BS na Hansen, BS Safety, nnabata, pharmacokinetics nke otu na otutu doses nke alpha-MSG na-eme ogologo oge analogues na oke ibu na oke ibu.Kinetics na pharmacodynamics.J. Clin.Pharmacodynamics.54, 394–404 (2014).
Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogues. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogues.Lau, J., F., Kruse, T., Linderoth, L. na Togersen, H. New glucagon analogues. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. 新型胰高血糖素类似物。 Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H.Lau, J., F., Cruz, T., Linderoth, L. na Togersen, H. New glucagon analogues.Patent US WO2011/117416 A1 (2011).
Ward, BP et al.Lipidation nke peptides na-edozi ihe owuwu iji kwalite ọrụ ndu.Moore.metabolism.2, 468–479 (2013).Ọrụ a na-egosiputa ọrụ nke eriri akụkụ fatty acid n'ịchọpụta nkwụsi ike nhazi na njikọ nke ndị na-anabata ọgwụ peptide.
Koskun T. et al.LY3298176, GIP dual novel na GLP-1 agonist receptor maka ọgwụgwọ ụdị ọrịa shuga 2: site na nchọpụta ruo na akaebe ụlọ ọgwụ nke echiche.Moore.metabolism.18, 3-14 (2018).Akwụkwọ a na-egosi atụmatụ nke GLP-1/GIP co-agonist nke mbụ enwetara fatty acid maka nchịkwa otu ugboro kwa izu n'ụlọọgwụ.
Kjeldsen, TB et al.Injinia molecular nke insulin icodec, analog nke insulin acylated mbụ na-eme otu ugboro kwa izu n'ime mmadụ.J. Ọgwụ.Chemical.64, 8942–8950 (2021).Akwukwo a gosiputara mmepe izizi nke fatty acid eweputara insulin otu ugboro kwa izu.
van Witteloostein, SB et al.Neoglycolipids maka peptides na-arụ ọrụ ogologo oge: analog nke glucagon-dị ka peptide 1 na-ejikọta onwe ya nwere ihe na-ejikọta albumin na ike dị elu na vivo.Moore.ọgwụ.14, 193–205 (2017).
Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. Acylated heptapeptide na-ejikọta albumin na nnukwu mmekọrịta yana ngwa dị ka mkpado na-enye peptides ogologo oge. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. Acylated heptapeptide na-ejikọta albumin na nnukwu mmekọrịta yana ngwa dị ka mkpado na-enye peptides ogologo oge.Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. na Haynes, S. Acylated heptapeptide na-ejikọta albumin na nnukwu mmekọrịta, na iji ya dị ka akara na-enye peptide na-arụ ọrụ ogologo oge. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 酰化七肽以高亲和力结合白蛋白，并作为栕签揾 Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 鎄化七peptide以高亲和力设计白白约筒，使用设训承用设设论承用井设论承用井设论承用井设论扡扡扡用井设论承用井设论承扡扡扡扡用井设。Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. na Haynes, S. Acylated heptapeptides na-ejikọta albumin na nnukwu mmekọrịta ma na-eje ozi dị ka akara maka nnyefe peptide na-eme ogologo oge.Mba.kwukọrịta 8, 16092 (2017).
Oge nzipu: Sep-08-2022
